The key to the facility was symbolically handed over to Hariolf Kottmann, CEO, Clariant, Ilse Aigner, Bavarian minister, Andre Koltermann, Jens Stephan from Clariant and Dr Haralabos Zorbas, IBB Netzwerk GmbH.
MUNICH, GERMANY: Clariant International Ltd said it officially opened its new biotechnology research centre in Planegg near Munich. The move was prompted by an expansion of the company’s activities having around 100 staff members. The new building with its laboratory and office space of over 6000 square metre offers ultra-modern lab facilities for research work. The team researches on development of sustainable products and processes based on renewables, it said.
In a ceremony attended by Ilse Aigner, the Bavarian minister for economic affairs, media, energy and technology, the key to the facility was symbolically handed over to CEO Hariolf Kottmann and the head of Clariant’s group biotechnology Andre Koltermann.
“Alongside the Clariant innovation centre (CIC) in Frankfurt, the new Clariant Biotech Center (CBC) is another important global research facility for our company,” said Hariolf Kottmann in an address delivered to over 100 representatives from the worlds of politics and business.
“The inauguration of this new biotechnology centre in Planegg is visible testimony to the importance of Bavaria as a center of research,” said Aigner.
“Establishing a dedicated research center for biotechnology in its own building right at the heart of one of Europe’s biggest biotech hubs is doing far more than just sending out a clear statement,” said Andre Koltermann.
Since 2006, the group biotechnology has successfully implemented projects in the field of renewable raw materials. The focus of this strategic unit is on the development of sustainable bio-based products and processes in the field of chemicals and biofuels, it said.
© Worldofchemicals News